首页> Scientific reports> Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition.

Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ramadevi,Subramani

第一单位： Center of Excellence in Cancer Research, Department of Biomedical Sciences MSB1, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, Texas-79905.

作者： Ramadevi,Subramani ^[1] ; Elizabeth,Gonzalez ^[2] ; Arunkumar,Arumugam ^[1] ; Sushmita,Nandy ^[1] ; Viviana,Gonzalez ^[3] ; Joshua,Medel ^[2] ; Fernando,Camacho ^[2] ; Andrew,Ortega ^[3] ; Sandrine,Bonkoungou ^[2] ; Mahesh,Narayan ^[3] ; Alok kumar,Dwivedi ^[4] ; Rajkumar,Lakshmanaswamy ^[5]

作者单位： Center of Excellence in Cancer Research, Department of Biomedical Sciences MSB1, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, Texas-79905. ^[1] Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, El Paso, Texas-79905. ^[2] The University of Texas at El Paso, El Paso, TX 79968. ^[3] Biostatistics and Epidemiology Consulting Laboratory, Texas Tech University Health Sciences Center, El Paso, Texas-79905. ^[4] Center of Excellence in Cancer Research, Department of Biomedical Sciences MSB1, Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, El Paso, Texas-79905.;Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, El Paso, Texas-79905. ^[5]